AbbVie (NY:ABBV)

265.76 +2.94 (+1.12%)

Official Closing Price Updated: 7:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

99 100 Next >

2 Top Dividend Stocks That Could Set You Up for Life ↗

April 09, 2025

Via The Motley Fool

Dr. Oz Officially Confirmed as Head of the Centers for Medicare and Medicaid Services. Here's What Retirees Need to Know So Far. ↗

April 09, 2025

Via The Motley Fool

Topics Government

3 Dividend Stocks to Buy and Hold for the Next Decade ↗

April 06, 2025

Via The Motley Fool

Topics Economy Intellectual Property

2 Dividend Stocks to Buy Hand Over Fist in April ↗

April 05, 2025

Via The Motley Fool

Trump's Tariff Exemptions Include Semiconductors, Pharmaceuticals, Oil And More ↗

April 03, 2025

President Donald Trump on Wednesday announced a slew of tougher-than-anticipated tariffs, but there are some notable exemptions to the steep levies. Here's a look at which products and sectors are...

Via Benzinga

Topics Government World Trade

3 High-Yielding Dividend Stocks That Retirees Can Buy and Forget About ↗

April 03, 2025

Via The Motley Fool

Biotech Stocks Dive After Trump Tacks On 20% European Tariff. Why AbbVie, Merck Could Be Exposed. ↗

April 02, 2025

It's unclear whether pharmaceutical goods could be exempt from tariffs. A number of drugmakers manufacture ingredients abroad.

Via Investor's Business Daily

Topics Economy Government World Trade

Looking At AbbVie's Recent Unusual Options Activity ↗

April 01, 2025

Via Benzinga

Decoding AbbVie's Options Activity: What's the Big Picture? ↗

March 31, 2025

Via Benzinga

Meta, Snowflake, PayPal And Health Care Stock On CNBC's 'Final Trades' ↗

March 31, 2025

Via Benzinga

Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades. ↗

March 31, 2025

Via The Motley Fool

Topics Intellectual Property Retirement

MarketBeat Week in Review – 03/24 - 03/28

March 29, 2025

Markets got a double dose of bad news about inflation and consumer confidence; next week, the Trump tariffs and Jobs report are likely to keep volatility high

Via MarketBeat

Topics Economy Government World Trade

3 Relatively Safe Stocks to Buy Right Now ↗

March 29, 2025

Via The Motley Fool

Topics Intellectual Property

Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too? ↗

March 28, 2025

Via The Motley Fool

Topics ETFs Economy Government

Retired At 58, He 'Spent Between $1M-$2M On Stocks' – Investor Who Built An 8% Yield Portfolio And Lives Off Dividends Shares Top Holdings ↗

March 27, 2025

Via Benzinga

From Rookie Mistakes To $10K/Year In Dividends – Military Veteran Who 'Made A Few Great Plays' Shares His 10 Biggest Bets ↗

March 27, 2025

Via Benzinga

2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income ↗

March 26, 2025

Via The Motley Fool

Stocks Going Ex Dividend In April 2025 ↗

March 25, 2025

The following is a short list of some of the many stocks going ex-dividend during the next month, which can be helpful for traders and investors interested in the stock trading technique known as...

Via Talk Markets

Topics Stocks / Equities

What's going on in today's session: S&P500 movers ↗

March 25, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.

Via Chartmill

Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside ↗

March 25, 2025

Avalo Therapeutics' AVTX-009 is advancing in hidradenitis suppurativa, with Phase 2 data expected in 2026. Stifel initiates coverage with a $36 price target.

Via Benzinga

Tuesday's session: top gainers and losers in the S&P500 index ↗

March 25, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.

Via Chartmill

Smart Money Is Betting Big In ABBV Options ↗

March 25, 2025

Via Benzinga

3 Healthcare Stocks in the Doghouse

March 25, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

Via StockStory

Topics Stocks

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today ↗

March 24, 2025

Via Benzinga

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

March 24, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Moderna (NASDAQ:MRNA) and the best and worst...

Via StockStory

Topics Artificial Intelligence

Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week ↗

March 23, 2025

Investors reacted to insider buying, clinical trial updates, and strategic business shifts that happened in the week ended March 21, 2025.

Via Stocktwits

AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market

March 23, 2025

Abbvie made an all-time high after announcing an agreement that puts it in the weight loss market; but that just continues a general uptrend in ABBV stock

Via MarketBeat

Is AbbVie Gaining or Losing Market Support? ↗

March 21, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 21, 2025

Via Benzinga

AbbVie Options Trading: A Deep Dive into Market Sentiment ↗

March 20, 2025

Via Benzinga

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.